The Influence of Coronary Chronic Total Occlusion on Myocardial Perfusion on Computed Tomography

CompletedOBSERVATIONAL
Enrollment

27

Participants

Timeline

Start Date

February 1, 2020

Primary Completion Date

July 1, 2022

Study Completion Date

July 1, 2022

Conditions
Coronary OcclusionMyocardial IschemiaMyocardial Perfusion ImagingPercutaneous Coronary Intervention
Interventions
DIAGNOSTIC_TEST

computed tomography perfusion imaging

The new-generation dual-source computed tomography scanner Somatom® Force will be used for all CTP studies. Myocardial perfusion will be evaluated in a stress dynamic CT protocol. The scan range will be determined based on a low-dose non-contrast scan. Subsequently, regadenoson will be administered intravenously at a single dose of 0.4 mg, and followed after 50 seconds delay by 35 mL of the iodinated contrast agent (iohexol, concentration 350 mg I/mL) injected at the flow rate of 5 mL/s. Finally, low-dose non-contrast dual-energy CT scan will be performed 5-6 min after the dynamic scan to assess late enhancement of the myocardium.

Trial Locations (1)

04-628

National Institute of Cardiology, Warsaw

All Listed Sponsors
lead

National Institute of Cardiology, Warsaw, Poland

OTHER

NCT04465526 - The Influence of Coronary Chronic Total Occlusion on Myocardial Perfusion on Computed Tomography | Biotech Hunter | Biotech Hunter